Pages that link to "Q22305820"

The following pages link to Strategies of tumor immune evasion (Q22305820):

Displaying 45 items.

• Cancer as an evolutionary and ecological process (Q22122026) (← links)
• Immunologically silent cancer clone transmission from mother to offspring (Q24650876) (← links)
• Life history trade-offs in cancer evolution (Q28657962) (← links)
• Different regulation of MHC class I antigen processing components in human tumors (Q30319116) (← links)
• Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma (Q33317415) (← links)
• FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy (Q33320890) (← links)
• DNA vaccines: developing new strategies against cancer (Q33756622) (← links)
• CD137 enhancement of HPV positive head and neck squamous cell carcinoma tumor clearance (Q35600651) (← links)
• An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer. (Q36085118) (← links)
• Adaptive immunity does not strongly suppress spontaneous tumors in a Sleeping Beauty model of cancer (Q36754562) (← links)
• Plasmid DNA and viral vector-based vaccines for the treatment of cancer (Q36909996) (← links)
• In vivo tumor secretion probing via ultrafiltration and tissue chamber: implication for anti-cancer drugs targeting secretome (Q37090386) (← links)
• An evolutionary explanation for the perturbation of the dynamics of metastatic tumors induced by surgery and acute inflammation (Q37129834) (← links)
• Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells. (Q37461075) (← links)
• Trichosanthin enhances anti-tumor immune response in a murine Lewis lung cancer model by boosting the interaction between TSLC1 and CRTAM. (Q37728221) (← links)
• DNA vaccination: using the patient's immune system to overcome cancer (Q37825422) (← links)
• Immunotherapy in nonmelanoma skin cancer (Q38014084) (← links)
• Pembrolizumab: a novel antiprogrammed death 1 (PD-1) monoclonal antibody for treatment of metastatic melanoma (Q38540340) (← links)
• Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer (Q38590722) (← links)
• Personalized Therapy of Small Cell Lung Cancer (Q38679311) (← links)
• Canine parvovirus NS1 protein exhibits anti-tumor activity in a mouse mammary tumor model. (Q38806071) (← links)
• Sodium valproate sensitizes non-small lung cancer A549 cells to γδ T-cell-mediated killing through upregulating the expression of MICA. (Q39114878) (← links)
• Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells? (Q39177284) (← links)
• Methylation-specific ligation detection reaction (msLDR): a new approach for multiplex evaluation of methylation patterns (Q39481853) (← links)
• Autologous CTL response against cancer stem‐like cells/cancer‐initiating cells of bone malignant fibrous histiocytoma (Q39553499) (← links)
• Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination. (Q39767227) (← links)
• The CD8+population of LAK cells can lyse both HLA-positive and HLA-negative cancer cell lines (Q39817679) (← links)
• Anti-tumor immunostimulatory effect of heat-killed tumor cells (Q40008171) (← links)
• Administration of the cytotoxic complex Tag7-Hsp70 to mice with transplanted tumors inhibits tumor growth (Q40099670) (← links)
• Cancer vaccine development: designing tumor cells for greater immunogenicity (Q42384053) (← links)
• A study of tumour growth based on stoichiometric principles: a continuous model and its discrete analogue (Q42976065) (← links)
• The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas (Q43289306) (← links)
• Classifying the evolutionary and ecological features of neoplasms (Q45067426) (← links)
• Innate immunity protein Tag7 (PGRP-S) activates lymphocytes capable of Fasl-Fas-dependent contact killing of virus-infected cells. (Q45325513) (← links)
• Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer (Q48097366) (← links)
• CD3+ CD8+ NKG2D+ T Lymphocytes Induce Apoptosis and Necroptosis in HLA-Negative Cells via FasL-Fas Interaction. (Q48127699) (← links)
• The Amount of Surface HLA-I on T Lymphocytes Decreases in Breast Infiltrating Ductal Carcinoma Patients (Q51450535) (← links)
• Immunization with a HSP65-HER2 fusion peptide selectively eliminates HER2(+) B16 melanoma cells in a xenograft tumor mouse model. (Q54478329) (← links)
• Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies. (Q55085319) (← links)
• Tag7 (PGLYRP1) Can Induce an Emergence of the CD3+CD4+CD25+CD127+ Cells with Antitumor Activity. (Q55285823) (← links)
• Lymph node metastasis density and growth pattern as independent prognostic factors in advanced esophageal squamous cell carcinoma (Q80848518) (← links)
• NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic (Q83186138) (← links)
• Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer (Q89646821) (← links)
• Cancer immunotherapy using the Fusion gene of Sendai virus (Q92432281) (← links)
• The Mutator Phenotype: Adapting Microbial Evolution to Cancer Biology (Q92857979) (← links)